Kendyl Schaefer Selected Research

Eszopiclone (Lunesta)

4/2011	A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
3/2010	Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
2/2010	A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
10/2009	Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference.
6/2009	Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.
6/2008	A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
5/2008	Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
8/2007	Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
1/2007	Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kendyl Schaefer Research Topics

Disease

9	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2011 - 01/2007
5	Asthma (Bronchial Asthma) 01/2008 - 01/2004
2	Anxiety Disorders (Anxiety Disorder) 04/2011 - 05/2008
2	Major Depressive Disorder (Major Depressive Disorders) 04/2011 - 03/2010
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2008 - 08/2006
1	Headache (Headaches) 02/2010
1	Nasopharyngitis 02/2010
1	Exercise-Induced Asthma (Asthma, Exercise Induced) 11/2007
1	Fatigue 08/2007
1	Sleepiness 08/2007
1	Hypersensitivity (Allergy) 11/2004

Drug/Important Bio-Agent (IBA)

9	Eszopiclone (Lunesta)FDA Link 04/2011 - 01/2007
6	Levalbuterol (Xopenex)FDA LinkGeneric 01/2008 - 01/2004
4	Albuterol (Salbutamol)FDA LinkGeneric 01/2008 - 01/2004
2	Escitalopram FDA Link 04/2011 - 05/2008
2	Fluoxetine (Prozac)FDA LinkGeneric 04/2011 - 03/2010
1	Antidepressive Agents (Antidepressants)IBA 04/2011
1	Pyridinolcarbamate (P23)IBA 04/2011
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 04/2011
1	Zolpidem (Ambien)FDA LinkGeneric 06/2008
1	Hypnotics and Sedatives (Sedatives)IBA 08/2007
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2006
1	Prednisone (Sone)FDA LinkGeneric 05/2006

Therapy/Procedure

2	Therapeutics 04/2011 - 05/2006